Chair Zhao Yan is steering the company away from hype-driven marketing, investing in synthetic biology to rebuild growth and ...

It has been suggested that, for Korea's regional bio clusters to attain global competitiveness, there is a need for a national-level platform that ...

Also, there’s still no easy way to test AI designs of larger genomes. While some viruses can ‘boot up’ just from a DNA strand ...

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the completion of enrollment for REGENERATE MSA-101, its Phase 1 ...

Regeneron Pharmaceuticals said on Wednesday its experimental treatment for a rare genetic disorder that affects bone tissue has met the main goal of a late-stage trial.

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New ...